Pivotal bioVenture Partners Fund I, L.P. [Rocket]

Date	Name	Symbol	Type	Security	Shares	Price	Value	Ownership	Reported
08/01/2023	Inozyme Pharma, Inc.	INZY	Purchase	Common Stock	119k	$4.80	$571.4k	See footnotes	08/01/2023
08/01/2023	Inozyme Pharma, Inc.	INZY	Purchase	Common Stock	714.3k	$4.80	$3.4M	See footnotes	08/01/2023
04/19/2022	Inozyme Pharma, Inc.	INZY	Purchase	Common Stock	1.1M	$3.69	$3.9M	See footnotes	04/19/2022
07/28/2020	Inozyme Pharma, Inc.	INZY	Conversion	Series A-2 Convertible Preferred Stock	10.5M	$0.00	$0	See footnote	07/28/2020
07/28/2020	Inozyme Pharma, Inc.	INZY	Purchase	Common Stock	187.5k	$16.00	$3M	See footnote	07/28/2020
07/28/2020	Inozyme Pharma, Inc.	INZY	Conversion	Common Stock	1.4M	$0.00	$0	See footnote	07/28/2020
06/30/2020	Akouos, Inc.	AKUS	Conversion	Common Stock	1.5M	$0.00	$0	See footnote	06/30/2020
06/30/2020	Akouos, Inc.	AKUS	Purchase	Common Stock	294.1k	$17.00	$5M	See footnote	06/30/2020
06/30/2020	Akouos, Inc.	AKUS	Conversion	Series B Preferred Stock	1.5M	$0.00	$0	See footnote	06/30/2020
09/28/2018	Entasis Therapeutics Holdings Inc.	ETTX	Purchase	Common Stock	337.7k	$15.00	$5.1M	See Footnote	09/28/2018
09/28/2018	Entasis Therapeutics Holdings Inc.	ETTX	Conversion	Common Stock	458.4k	$0.00	$0	See Footnote	09/28/2018
09/28/2018	Entasis Therapeutics Holdings Inc.	ETTX	Conversion	Series B-1 Tranche A Convertible Preferred Stock	7.4M	$0.00	$0	See Footnote	09/28/2018
09/28/2018	Entasis Therapeutics Holdings Inc.	ETTX	Conversion	Series B-1 Tranche B Convertible Preferred Stock	9.5M	$0.00	$0	See Footnote	09/28/2018
09/28/2018	Entasis Therapeutics Holdings Inc.	ETTX	Conversion	Common Stock	359.3k	$0.00	$0	See Footnote	09/28/2018